Academy of Physicians
in Clinical Research

Academy of Physicians
in Clinical Research

News from SCRIP

APCR Members can get a free trial to SCRIP and a discount on a SCRIP subscription by contacting John Lezcano from SCRIP directly at the information below. 

John Lezcano
Corporate Account Manager

Pharma intelligence | informa
T: (212) 652-2678
M: (631) 807-4971

AstraZeneca's Imfinzi Cements Market Position In Lung Cancer Segment With UK NICE Okay

Thu, 03/28/2019 - 12:37am

But because of the remaining uncertainty in the clinical evidence for this "potentially curative treatment," – Imfinzi for Stage III NSCLC – UK...

      Related Stories 

Basaglar Saved Medicaid Millions, Highlighting Benefits Of Competition, JAMA Analysis Shows

Wed, 03/27/2019 - 2:15pm

Researchers analyzed usage rates, market share and reimbursement information for the long-acting insulins Lantus and Basaglar to determine the impact from...

      Related Stories 

FDA Backs Novartis MS Pill Mayzent With Broad Label

Wed, 03/27/2019 - 8:46am

Mayzent is the first oral therapy proven to delay progression in patients with secondary progressive multiple sclerosis and Novartis pharma...

      Related Stories 

Blackstone Bets On Pharma In First Japan Buy, But Why?

Tue, 03/26/2019 - 6:40pm

Major private equity group Blackstone buys into pharma for its first acquisition in Japan, but amid challenges in the sector...

      Related Stories 

Publisher’s Spotlight: 2019 CARE Awards Finalists

Tue, 03/26/2019 - 1:39pm

Informa Pharma Intelligence is delighted to announce the shortlist for the 2019 Clinical and Research Excellence Awards, to be presented...

      Related Stories 

Bluebird’s Gene Therapy LentiGlobin Coming Into Land In The EU?

Tue, 03/26/2019 - 7:41am

Two charities say a positive CHMP opinion has been given to bluebird bio’s transfusion-dependent β-thalassemia gene therapy LentiGlobin at the...

      Related Stories 

Proteostasis Puts Best Face On Unspectacular CF Combo Data

Mon, 03/25/2019 - 2:40pm

With data showing a lung function and sweat chloride benefit for its proprietary CFTR-modulating triplet, Proteostasis says it’s moving ahead...

      Related Stories